Taxotere Benefits
Links shared publicly online about this topic
Medical News: Sequential Docetaxel: No Benefit in Early Breast Cancer - in Hematology/Oncology, Breast Cancer from MedPage Today
medpagetoday.com — “WHEELING, W.Va. -- Adding docetaxel (Taxotere) to standard anthracycline-based adjuvant chemotherapy failed to improve five-year survival or recurrence in a large randomized trial, British researchers” View full resource at medpagetoday.com
Most Recently Shared on May 15, 2009 at 4:14 pm By:
Sequential Docetaxel: No Benefit in Early Breast Cancer http://medpagetoday.com/14234
UPDATE 2-US FDA cites Sanofi on breast cancer drug marketing | Reuters
reuters.com — “* FDA says journal reprint is misleading * Materials overstated Taxotere's benefits -FDA * Sanofi: materials appropriate, working with FDA (Adds company comment, paragraphs 6-7) WASHINGTON, May” View full resource at reuters.com
Most Recently Shared on May 14, 2009 at 2:02 pm By:
eyeonfda Pharma and Health Lawyer
FDA cites Sanofi on breast cancer drug marketing http://twurl.nl/n7jjg0
Benefit of New Taxane Affirmed in Prostate CA (CME/CE) - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- The recently approved chemotherapy agent cabazitaxel (Jevtana) improves overall survival in metastatic, hormone-refractory prostate cancer resistant to docetaxel (Taxotere), researchers affirmed.” View full resource at qualitypointtech.net
Most Recently Shared on September 30, 2010 at 11:24 pm By:
Benefit of New Taxane Affirmed in Prostate CA (CME/CE): (MedPage Today) -- The recently approved chemotherapy agen... http://bit.ly/9hzPK9
Positive Test for Prostate Chemotherapy Drug Cabazitaxel - NYTimes.com
nytimes.com — “The drug, cabazitaxel, could become a new last-ditch treatment when another type of chemotherapy is no longer effective.” View full resource at nytimes.com
Most Recently Shared on March 4, 2010 at 6:52 pm By:
H. Jack West, MD Internist, Health Executive, Oncologist, Physician, and Doctor
New chemo cabazitaxel shows survival benefit in met #prostatecancer; expect approval late this yr, for after Taxotere: http://nyti.ms/cEUrpL
Medical News: Benefit of New Taxane Affirmed in Prostate CA - in Oncology/Hematology, Prostate Cancer from MedPage Today
medpagetoday.com — “The recently approved chemotherapy agent cabazitaxel (Jevtana) improves overall survival in metastatic, hormone-refractory prostate cancer resistant to docetaxel (Taxotere), researchers affirmed.” View full resource at medpagetoday.com
Most Recently Shared on September 30, 2010 at 11:56 pm By:
Benefit of New Taxane Affirmed in Prostate CA (CME/CE) http://bit.ly/avKtBy
Medical News: Benefit of New Taxane Affirmed in Prostate CA - in Oncology/Hematology, Prostate Cancer from MedPage Today
medpagetoday.com — “The recently approved chemotherapy agent cabazitaxel (Jevtana) improves overall survival in metastatic, hormone-refractory prostate cancer resistant to docetaxel (Taxotere), researchers affirmed.” View full resource at medpagetoday.com
Most Recently Shared on September 30, 2010 at 11:48 pm By:
Drugs and Devices OW OW Health
Benefit of New Taxane Affirmed in Prostate CA: The recently approved chemotherapy agent cabazitaxel (Jevtana)... http://bit.ly/9CKzDI #drug
Drug May Extend Life When Breast Cancer Spreads - myOptumHealth
myoptumhealth.com — “Read the news article Drug May Extend Life When Breast Cancer Spreads at www.myOptumHealth.com” View full resource at myoptumhealth.com
Most Recently Shared on May 26, 2009 at 9:58 pm By:
Drug May Extend Life When Breast Cancer Spreads: Study funded by pharmaceutical company finds benefits in Abraxane http://tinyurl.com/olu6e5
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
MedPage Today
Daily, peer reviewed medical news for clinicians
-
eyeonfda
Author of the blog Eye on FDA - www.eyeonfda.com
-
MedicalFeed
Medical news and updates about medical articles and discussion in Google knols and in many medical websites.
Advertisement
